UPR Cayey ‘19 Chemistry | M3 @ University of Minnesota MSTP (MD-PhD) | Future Pathologist 🔬
Joined January 2013
- Tweets 738
- Following 2,845
- Followers 890
- Likes 4,028
40 Photos and videos
Headed to #USCAP2026 for a couple of days of great science, insightful discussions, and connecting with future colleagues in pathology!
See you all there!
@TheUSCAP
#PathX
1
6
743
José Valentín López retweeted
7 May 2024
Analysis of B7-H3 in >150,000 cancer samples from >50 histologies. A new therapeutic target is born. Congrats to Carly Miller on her first-author paper. Thanks also to @CarisLife for their collaboration. aacrjournals.org/cancerresco…
3
12
60
3,474
5 May 2024
Great discussions happening at the 2024 GRS and GRC on Lipidomics!
3
395
24 Apr 2024
Its out! Check out our latest review article “Androgen receptor and estrogen receptor variants in prostate and breast cancers” in the Journal of Steroid Biochemistry and Molecular Biology 🧫 🧬
authors.elsevier.com/a/1izxk…
5
14
1,033
José Valentín López retweeted
1 Jul 2023
@UMNChemistry’s summer intramural softball was back after a Covid-hiatus!
Congrats to The Dynamic Scatterers for taking 3rd place! 🙌🏽✨💪🏽
@TLOkeefe12 @RealMMA10 @W_AlvarezReyes @Finetraces786 @caseyh2os lots of friends!
9
19
1,128
José Valentín López retweeted
6 Jun 2023
Wonderful presentation by @AlbigesL @GustaveRoussy arguing for doublet v triplet tx. Slides updated to reflect data from @brian_rini @VUMCDiscoveries & @DrTHut @TheUSONetwork presented at #ASCO23 just yesterday (wow!). Come join us in Room E451!
2
18
51
23,838
José Valentín López retweeted
5 Jun 2023
Thx to 🌟@OncMedEdCoP team for creating a home for anyone interested in #OncMedEd. ✨All✨ are welcome regardless of profession, training, specialty, or @ASCO membership.
Special thx to @JenSchwartzIUSM and @doctormb1 for our #ASCO23 events!
Join us: surveymonkey.com/r/ASCOMedEd…
2
8
17
2,602
5 Jun 2023
3
1
48
2,788
José Valentín López retweeted
4 Jun 2023
Thanks for sharing such an important point! There are so many side-effects that are not seeing! #LCSM #ASCO23
4 Jun 2023
Thank you @bensolomon1 for recognizing that while it’s important to celebrate the wins, it’s critical to remember that tolerable is relative and can change over time for those on chronic treatment.
#LCSM #ASCO23 @EGFRResisters
1
3
295
José Valentín López retweeted
4 Jun 2023
PROSPECT:Can we omit RT in selected patients?
☢️Preoperative Chemotherapy with Selective Chemoradiation versus Chemoradiation for Locally Advanced Rectal Cancer:
☢️Yes! There are no differences regarding DFS, OS, pCR, and locoregional reoccurrence!
@asco @oncoalert #ASCO23
1
20
27
29,363
José Valentín López retweeted
4 Jun 2023
#ASCO23 Plenary session underway with results of the PROSPECT trial
🎗️Compared neoadjuvant CRT vs FOLFOX
🎗️ Non-inferiority DFS was met
🎗️Path CR and QOL similar
🎗️Neoadjuvant FOLFOX, with selective use CRT, is an effective tx for pts with CT2N , cT3N-, or cT3N rectal cancer
7
12
1,893
4 Jun 2023
Very interesting session on Patient-Centric Clinical Trial Design in GU Cancers happening now at #ASCO23
1
222
3 Jun 2023
It’s time for the 2023 Medical Student & Resident Abstract Forum.
Come check out my poster (22) in S103.
#ASCO23 @LatinxOncology
5
457
José Valentín López retweeted
30 May 2023
ASCO 23 GU cancer highlight @ChrisSweens1 @brian_rini CONTACT-3, THOR, PEACE1, 5 yr KN426 and much more. anchor.fm/the-uromigos/episo…
27
68
26,904